Why Attend
Our mission is to engage all key participants in the value chain so we can address the full scope of how animal health impacts pet owners, veterinarians, and farmers today.
Across regions of Asia, prediction, prevention, and treatment of disease in animals are becoming increasingly important, with Japan and China continuing to lead the charge, but we are seeing new markets emerging including Thailand, India, Indonesia, Vietnam, Singapore, South Korea, and Malaysia. One of the biggest challenges in this region for large animal health companies is sourcing innovation, and for start-ups, it is entering new markets.
Who You Will Meet
Attendees will represent the following key stakeholder groups in the Animal Health market
- Heads of Business Development, Animal Health, R&D from Multinational Pharmaceutical Companies
- CEOs, CSOs and Heads of Business Development from Emerging Animal Health Companies
- CEOs, Heads of Business Development, Product Discovery and Marketing from Incubators/ Accelerators, Contract Research Orgs, Consultants, Lawyers and other Service Providers
…all of the above with an interest in Livestock, Aquaculture and the Companion Animal markets
Attendees expected from the following key stakeholder groups and organizations
2023 Speakers

Mr. Kats Kato

Ms. Violet Chen

Mr. Yuki Ujimasa

Dr. Motoo Kobayashi

Mr. Yoshio Hase, CPA, MBA

Mr. Miles Yao

Mr. Jishu Shi

Dr. Yoshio Hirano

Dr. Tomohiro Yamaguchi

Dr. Klaus Hellmann

Mr.Toshikazu Fukui

Dr. Eka Dewi Wulandari

Ms. Matilda Ho

Jamie Brannan

Mr. Hongbin Hu

Mr. Leo Wein

Dr. Dante Palabrica D.V.M

Dr. Siraya Chunekamrai

Mr. Mike Wang

Mr. Kouji Tachibana

Mr. Philip Huggenberger

Mr. Vijay Teng

Dr. Arkhom Cheewakriengkrai

Dr. Ken Noda DVM
Innovation Showcase
The showcase is a unique opportunity for emerging companies with amazing technology to present in front of the industry’s most influential figures and investors. 5 start-ups, hand-picked by the Selection Committee, introduce themselves, their innovations and achievements on the main stage. This year, our finalists will be presenting products across health, nutrition and technology areas in companion and production animals
Applications are now closed - please look out for our finalist announcement next week.
Our Partners
Headline Partner
Zoetis
Website: https://www.zoetis.com/
As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers and ranchers. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics, and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $8.1 billion in 2022 with approximately 13,800 employees.
For more information, visit www.zoetis.com.
Platinum Associate Partner
ZENOAQ
Website: http://www.zenoaq.jp/english/index.html
ZENOAQ aims to create a shared and everlasting future for humans and animals. Amidst efforts to improve drug development, veterinary therapy and biotechnology, ZENOAQ strives to enhance the value of animals. The core activities in ZENOAQ are deeply connected with our customers, which in turn, affects their animals in many different ways. These connections form a network that is not just limited to Japan, but is something that will also reach across international borders, creating mutual benefit for both humans and animals in the future.
Senior Event Partners
MSD Animal Health
Website: https://www.msd-animal-health.com/
At MSD, known as Merck & Co., Inc., Rahway, N.J., USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than a century, we’ve been at the forefront of research, bringing forward medicines, vaccines and innovative health solutions for the world’s most challenging diseases. MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA, is the global animal health business of MSD. Through its commitment to The Science of Healthier Animals®, MSD Animal Health offers veterinarians, farmers, pet owners and governments one of the widest ranges of veterinary pharmaceuticals, vaccines and health management solutions and services as well as an extensive suite of connected technology that includes identification, traceability and monitoring products. MSD Animal Health is dedicated to preserving and improving the health, well-being and performance of animals and the people who care for them. It invests extensively in dynamic and comprehensive R&D resources and a modern, global supply chain. MSD Animal Health is present in more than 50 countries, while its products are available in some 150 markets. For more information, visit www.msd-animal-health.com.
Elanco
Website: www.elanco.com
Elanco Animal Health (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders, and society as a whole. With nearly 70 years of animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we’re driven by our vision of Food and Companionship Enriching life and our Elanco Healthy Purpose™ CSR framework – all to advance the health of animals, people and the planet.
Event Partners
AB7 Sante
Website: https://www.ab7group.com/en/home
AB7 Santé is a French Veterinary Pharmaceutical Laboratory that has been innovating for over 50 years in the field of Animal Health.
Fully integrated for better agility, AB7 is specialized in research, development, production, quality control, registration and sales of veterinary medicines, generics, OTC, biocides & pet care products for the global market.
With its industrial know-how over 2 certified units in France (GMP) and in the United States (EPA), AB7 is able to address specific manufacturing needs, from small series to large volumes, by ensuring a high level of quality and offering the capacity to adapt manufacturing resources, method and technology.
As a CDMO Company, we offer our partners pharmaceutical and non-pharmaceutical outsourcing activities from development to manufacturing by integrating an innovative, sustainable and responsible approach.
AB7 has continually invested in R&D and production capacities with a constant desire to develop its industrial know-how and to own state-of-the-art equipment for a relevant service in the field of pharmaceutical products within GMP standards. Our 5 R&D Laboratories with more than 45 specialists and our industrial equipments allow us to satisfy the requirements of both small and large pharmaceutical companies within a constructive partnership.
Specialized in exclusive drug delivery systems, AB7 supports its partners in the development of new innovative products and is able to provide full line of products with more traditional galenics.
At AB7, we aim to contribute to today's animal health and welfare challenges by working with international partners to achieve this mission together.
Animal Medicine Research Center of Da Bei Nong (DBN) Group
Animal Medicine Research Center of Da Bei Nong (DBN) Group, affiliated to DBN Science & Technology Group Co., Ltd., is dedicated to researching, developing, manufacturing and commercializing novel products of Animal Biologics. Till 2017, Center has completed numerous technology transfer in a total value of 350 million RMB which is ranked No.1 of the most productive animal vaccine R&D Center in China. Now we are one of the largest commercialized vaccine research and diagnostic test units for Animal Biologics, especially in swine and companion animals.
Our Mission is to improve animal health. The expectation is to the best contract research organization (CRO) for international animal health companies. With our advantages in understanding animal infection disease epidemics in China, resource of field isolates of pathogens and a dedicated R&D team, we are capable of developing advanced animal vaccines quickly. Currently, we have a number of vaccine technology transfers available. We are striving for continuous improvement in our performance by digging into the industrial potentials and creating a cutting-edge global R&D organization for animal health.
Argenta
Website: https://www.argentaglobal.com/
About Argenta™
Founded in New Zealand, Argenta’s talented and committed employees are dedicated to delivering excellence in animal health to customers around the world. With research and/or GMP manufacturing operations in Germany (KLIFOVET), New Zealand, Spain (Pen & Tec Consulting), the United Kingdom, and the United States, Argenta holds a unique position as the only combined global contract research organisation (CRO) and contract development and manufacturing organisation (CDMO) specialising in animal health.
Argenta operates from Molecule to Market in partnership with customers of all sizes from all corners of the world, supporting their research and development, clinical research, regulatory, scale-up and manufacturing needs along the veterinary product development journey.
The day-to-day ethos that drives Argenta forward is a mission focused on global partnerships, a Molecule to Market approach, and innovation. At the core of the business and the organisation is collaboration – among the global employee base and with their customers.
Argenta proudly partners with a vast range of global customers. Our services and facilities scale to meet the requirements of the largest multinationals, whilst, at the other end of the spectrum, offering start-ups and small companies capabilities and solutions that help bring their ideas to fruition.
For more information, please visit www.argentaglobal.com
Clinglobal
Website: https://www.clinglobal.com/
CLINGLOBAL is an Animal Health Services company established during 2016 in Mauritius acting as a contract holding and centralised service provider for the ever expanding “Clin” group of companies.
Our unique business model allows the animal health industry and community to benefit from our simplified contracting solutions by having a customizable all-inclusive approach and the delivery of animal health research projects and services.
Transpharmation
Website: https://www.transpharmation.com/
Transpharmation is an in vivo contract research organization focused on therapeutic discovery and lead selection in both the central nervous system and the animal health spaces. Recognised by scientists worldwide for research that delivers life-changing medicines, foods, nutraceuticals, and devices to improve health of humans and companion animals. Improving health through science will always remain our passion. Our clients benefit from decades of experience in cross-species and cross-therapeutic translational biology across our preclinical services. From early PK and safety through proof of concept in indications related to neurology, neuropsychiatry, behaviour, metabolic disease, dermatology and health span, Transpharmation is the go-to collaborator for preclinical success.
Consulting Partner
AHRMS, Inc.
Website: https://ahrms.jp/wp/
Tokyo-based AHRMS, Inc., have provided regulatory consultancy and marketing services to Japanese and foreign animal health companies since 2006.
We also register animal health products by acting as D-MAH (designated marketing authorization holder) for foreign manufacturers. This means that our client companies can receive marketing approvals from Japanese authorities without establishing their subsidiary in Japan.
Our services cover animal medicines, biologicals, medical devices, and in vitro diagnostic kits. We strongly hope that we could support your entering into Japanese markets.
PARTNER WITH US
Based on your objectives, we can create bespoke packages designed specifically for you – from presenting your expertise on the main stage, to hosting a private dinner. You can partner with us showcase your brand and make valuable new connections. Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding & Networking.
To discuss your objectives and partnership opportunities please contact [email protected].
Interested in a media partnership?
We'd love to hear from you and how we can support one another to connect with the industry. Contact [email protected].
Download 2023 Agenda
Animal Health, Nutrition and Technology Innovation Asia 2023 returns to Tokyo with industry-leading speaker line-up to give you insights into the biggest opportunities in the Asia Pacific region.
Fill out this form to view the latest agenda!
Download Full Agenda
Conference Packages
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
Registration ends in
— October 22, 2023 —
Testimonials
"This is a unique event for our animal health industry. It brings local and international players together, and provides an excellent platform to build business partnerships.”
Tony Zilong Tan, Z-Link Biotech Co. Ltd.
“This meeting is a very exciting one – it’s a platform to meet everyone from Chinese animal health and International animal health companies, and to introduce them to one-another. This way you save time and it gives you more chance to keep ahead of the innovations.”
Tingwu Xue, China Animal Husbandry Group (CAHG)
“I think this is a great meeting for companies to come together and find out what the common challenges are and how they can work together. I’m really impressed!"
Jishu Shi, U.S.-China Centre for Animal Health
"Everybody’s here, you can have many meetings in one spot, learn how to work together, increase your network and search for ideas.”
Joachim Hasenmaier, Boehringer-Ingelheim
Venue Description
Venue
Hilton Tokyo, 160-0023, Shinjuku-Ku, 6-6-2 Nishi-Shinjuku, Japan
Join us at the Hilton Tokyo in October!
Please click here to benefit from our Special rate for accommodation at the Hilton Tokyo.
Marketing Solutions
Want to discover our bespoke marketing offerings?
View our Marketing Solutions Pack and learn more about our range of Lead Generation, Thought Leadership, Brand Awareness and Market Insight products.
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.